Study guide

12.4 Asthma, COPD and Respiratory Emergencies

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

12.4 Asthma, COPD and Respiratory Emergencies

Key Takeaways Explain This Topic AI

Sodium metabisulfite preservative in adrenaline-containing local anaesthetic can trigger bronchospasm in sulfite-sensitive asthmatics.

Samter's triad is severe asthma, chronic rhinosinusitis with nasal polyposis and aspirin or NSAID sensitivity, so NSAIDs must be avoided.

Acute asthma is treated with the patient upright, salbutamol 2 to 4 puffs (up to 10) through a spacer, and 999 if there is no rapid response.

Target oxygen saturation in COPD patients at risk of hypercapnic respiratory failure is 88% to 92%, delivered by a 24% or 28% Venturi mask.

Cardiac pain can refer to the left angle of the mandible and lower teeth, so unexplained jaw pain with exertion needs a cardiac differential.

Last updated: September 2026

4. Respiratory Disease: Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Respiratory disease impairs alveolar gas exchange and airway mechanics, presenting acute hazards during dental operative procedures.

Asthma: Pathophysiology and Clinical Triggers

Asthma is a chronic inflammatory disorder of the conducting airways characterized by bronchial hyperresponsiveness, reversible airflow limitation, mucosal oedema, and excessive mucous secretion.

Dental Triggers: In the dental environment, acute bronchospasm can be provoked by: acute psychological stress and fear, inhalation of cold dry air, dental stone/plaster dust, airborne powder from latex gloves, methyl methacrylate monomer vapour from acrylics, impression material colophony, and sulfite preservatives .

The Local Anaesthetic Preservative Trap: Local anaesthetic cartridges that contain a vasoconstrictor (such as adrenaline) also contain sodium metabisulfite or potassium metabisulfite as an antioxidant to prevent catecholamine oxidation. In approximately 5% to 10% of asthmatic patients (particularly steroid-dependent asthmatics), sulfites can trigger severe, acute IgE-mediated or non-IgE-mediated hypersensitivity reactions and life-threatening bronchospasm. If a patient gives a confirmed history of sulfite allergy, plain local anaesthetics (e.g., 3% mepivacaine plain or 4% prilocaine plain) must be used.

Aspirin-Exacerbated Respiratory Disease (AERD / Samter's Triad)

Aspirin-sensitive asthma affects up to 10% to 20% of adult asthmatic patients. It is characterized by the classic Samter's triad (or Widal's syndrome ):

Severe bronchial asthma .

Chronic rhinosinusitis with recurrent nasal polyposis .

  • Severe hypersensitivity to aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) . Arachidonic Acid
  • │
  • ┌──────────────────┴──────────────────┐
  • ▼ ▼
  • Cyclooxygenase-1 (COX-1) 5-Lipoxygenase (5-LOX)
  • [BLOCKED by Aspirin & NSAIDs] │
  • │ ▼
  • Loss of Prostaglandin E2 (PGE2) Massive Surge of Cysteinyl Leukotrienes
  • (Loss of Bronchoprotective Tone) (LTC4, LTD4, LTE4)
  • │
  • ▼
  • Profound Bronchoconstriction,
  • Mucosal Oedema & Fatal Bronchospasm

Molecular Mechanism: Aspirin and traditional non-selective NSAIDs (ibuprofen, naproxen, diclofenac, ketoprofen) irreversibly or reversibly block the cyclooxygenase-1 (COX-1) enzyme. This shunts all uninhibited arachidonic acid metabolism into the 5-lipoxygenase pathway , generating an uncontrolled surge of cysteinyl leukotrienes ( L T C 4 LTC_4 L T C 4 ​ , L T D 4 LTD_4 L T D 4 ​ , L T E 4 LTE_4 L T E 4 ​ ) . Concurrently, the synthesis of prostaglandin E 2 E_2 E 2 ​ ( P G E 2 PGE_2 PG E 2 ​ ), which exerts baseline bronchodilator and mast-cell stabilising effects, is abolished. The resulting leukotriene surge causes massive bronchoconstriction, mucosal hyperaemia, and rapid, potentially fatal asphyxiation.

Clinical Mandate: Aspirin and all NSAIDs are strictly contraindicated in patients with asthma who have a history of aspirin sensitivity or nasal polyposis. In clinical practice, paracetamol (or paracetamol with codeine) is the analgesic of choice. If paracetamol is insufficient, weak opioids (dihydrocodeine) may be considered, while monitoring for respiratory depression.

Chairside Asthma Management and Emergency Protocol

Pre-treatment Check: The patient must place their short-acting selective beta-2 adrenergic agonist inhaler ( Salbutamol 100 mcg/actuation , blue inhaler) directly on the bracket table. Verify that the canister is not empty.

Ultrasonic Scalers and Aerosols: Avoid ultrasonic scaling, air-polishers, and excessive water spray during periods of unstable asthma or in patients with active wheezing. Aerosol clouds and aspirating cool water mist trigger hyper-reactive bronchial smooth muscle contraction.

Acute Asthma Attack Protocol in the Dental Chair:

Stop dental treatment; remove all oral instruments and rubber dam.

Sit the patient upright and lean them slightly forward; do NOT lay the patient down (supine positioning increases work of breathing and orthopnoea).

Administer Salbutamol (100 mcg/puff) : deliver 2 to 4 puffs immediately, preferably via a large-volume spacer device (Volumatic / AeroChamber). Instruct the patient to take 4 to 5 tidal breaths per puff.

Reassure the patient and administer high-flow oxygen (10–15 L/min via non-rebreather reservoir mask).

If symptoms fail to resolve, administer 1 puff of Salbutamol every 30 to 60 seconds , up to a total of 10 puffs .

Call 999 immediately if the patient is unable to complete sentences in one breath, displays silent chest (absence of wheezing due to severe airflow cessation), develops cyanosis, has an oxygen saturation < 92 % < 92\% < 92% , or fails to improve following 10 puffs of salbutamol.

If the patient becomes exhausted, drowsy, or loses consciousness, prepare for intramuscular adrenaline ( 0.5 mg IM [0.5 mL of 1:1,000] in anterolateral thigh) as emergency bronchodilator therapy, assist ventilation with bag-valve-mask, and initiate basic life support.

Chronic Obstructive Pulmonary Disease (COPD)

COPD is a progressive, irreversible pulmonary disorder encompassing chronic bronchitis (chronic productive cough for ≥ 3 \ge 3 ≥ 3 consecutive months in ≥ 2 \ge 2 ≥ 2 successive years) and emphysema (abnormal permanent enlargement of airspaces distal to terminal bronchioles with destruction of alveolar walls and loss of elastic recoil).

Dental Considerations for COPD

Chair Positioning (Avoid Fully Supine): Patients with moderate-to-severe COPD suffer from significant diaphragmatic flattening and reduced chest wall compliance. Placing the dental chair in a flat or supine position forces the abdominal viscera superiorly against the diaphragm, causing acute mechanical orthopnoea, respiratory exhaustion, and severe dyspnoea. Always treat COPD patients in a semi-erect or fully upright position (at an angle of ≥ 45 degrees \ge 45\text{ degrees} ≥ 45 degrees ).

The Loss of Hypoxic Drive and Oxygen Hazard:

Pathophysiology: In healthy individuals, central chemoreceptors in the medulla oblongata are exquisitely sensitive to changes in arterial carbon dioxide ( P a C O 2 PaCO_2 P a C O 2 ​ ), which acts as the primary respiratory drive. In patients with end-stage chronic bronchitis and severe hypercapnia, the central chemoreceptors become chronically desensitized to elevated P a C O 2 PaCO_2 P a C O 2 ​ . Consequently, respiratory drive is maintained entirely by peripheral chemoreceptors (located in the carotid and aortic bodies) that fire in response to low arterial oxygen tension ( P a O 2 PaO_2 P a O 2 ​ )—the so-called hypoxic drive .

The Danger of High-Flow Oxygen: If uncontrolled high-flow oxygen (e.g., 10–15 L/min via non-rebreather mask, delivering > 60 − 80 % O 2 >60-80\%\text{ }O_2 > 60 − 80% O 2 ​ ) is administered to a severe COPD patient with chronic CO2 retention, the acute elevation of P a O 2 PaO_2 P a O 2 ​ abolishes the peripheral chemoreceptor firing. The sole remaining drive to breathe is abruptly extinguished, precipitating acute hypoventilation, hypercapnic respiratory acidosis, carbon dioxide narcosis, coma, and respiratory arrest .

Emergency Oxygen Guidance: If emergency oxygen is required in a COPD patient with respiratory distress, deliver controlled low-concentration oxygen via a 24% or 28% Venturi mask (at 2–4 L/min) , targeting oxygen saturations strictly between 88% and 92% , pending emergency medical arrival.

Sedation, Narcotics, and Rubber Dam Hazards:

Conscious Sedation: Intravenous midazolam is contraindicated in severe COPD due to its potent central respiratory depressant effects. Inhalation sedation with nitrous oxide/oxygen must be used with extreme caution or avoided in bullous emphysema, as nitrous oxide diffuses into closed air spaces 34 times faster than nitrogen leaves, expanding pulmonary bullae and precipitating a life-threatening spontaneous tension pneumothorax .

Opioid Analgesics: Opioids (codeine, dihydrocodeine, morphine) depress the medullary respiratory centre and suppress the cough reflex, promoting mucus plugging and hypoventilation. Avoid opioids; rely on paracetamol and non-opioid regimens.

Rubber Dam: In severe COPD patients who are obligatory mouth-breathers, placing a rubber dam can induce acute sensations of suffocation and severe respiratory distress. If rubber dam isolation is indispensable, use a nasal cannula for supplemental low-flow air/oxygen and ensure the nares remain completely unobstructed.

5. Clinical Traps, Pitfalls, and Worked Scenarios

Caution

Clinical Trap: Demands for Antibiotic Prophylaxis in High-Risk Patients: A 65-year-old male with a mechanical aortic valve replacement presents for surgical extraction of a fractured lower molar. The patient insists that his previous dentist always gave him 3 g of oral amoxicillin before treatment and demands a prescription, stating he will hold you legally responsible if he contracts endocarditis. Under UK GDC standards and NICE CG64, routine antibiotic prophylaxis is not indicated. Acceding to patient pressure without clinical justification violates UK antimicrobial stewardship. The correct management is to provide empathetic, structured explanation: explain that current UK evidence demonstrates antibiotics do not prevent endocarditis, that daily toothbrushing poses a greater cumulative risk, and that amoxicillin carries significant risks of fatal allergic reactions and antibiotic resistance. Document the detailed discussion in the clinical notes. If the patient refuses treatment without prophylaxis, offer to liaise with their cardiologist.

Warning

Clinical Trap: Misdiagnosing Jaw Pain as Odontogenic in Ischaemic Heart Disease: Myocardial ischaemia does not always present with classic retrosternal chest tightness. In up to 10% to 15% of patients—especially women, diabetics, and the elderly—cardiac ischaemia presents atypically as referred craniofacial pain . Ischaemic visceral afferent fibres travelling via cardiac sympathetic nerves (T1–T4) enter the spinal cord and converge with somatic pathways, projecting via interneurons to the spinal trigeminal nucleus. Consequently, angina or an acute MI may manifest solely as cramping, burning, or aching pain radiating to the left angle of the mandible, lower jaw, or teeth , provoked by walking or climbing stairs and relieved by rest. Extracting a sound mandibular molar because of "unexplained lower jaw pain" in a patient with cardiovascular risk factors is a catastrophic diagnostic blunder. Always take a complete cardiovascular history and inquire whether jaw pain is provoked by physical exertion.

Worked Clinical SBA Scenario

Scenario: A 71-year-old male presents to your dental surgery complaining of severe, constant throbbing pain from tooth 47. Medical history reveals a 15-year history of severe Chronic Obstructive Pulmonary Disease (COPD) with long-term home oxygen therapy, alongside Stage 2 hypertension treated with amlodipine. Clinical examination reveals acute periapical periodontitis associated with a non-restorable retained root of 47. Pre-operative blood pressure is recorded at 158 / 94 mmHg 158/94\text{ mmHg} 158/94 mmHg , and his baseline oxygen saturation on room air is 89 % 89\% 89% . While in the dental chair, the patient develops severe wheezing, breathlessness, and acute agitation.

Question: What is the immediate, correct sequence of clinical management for this patient regarding chair positioning, oxygen administration, and pharmacological intervention?

Analysis and Clinical Governance: The patient is experiencing an acute bronchospastic exacerbation of his severe COPD. Placing him flat in the dental chair would induce diaphragmatic splinting and worsen respiratory failure; he must be maintained upright or semi-reclined at ≥ 45 degrees \ge 45\text{ degrees} ≥ 45 degrees . Crucially, administering high-flow oxygen via a non-rebreather mask ( 10 − 15 L/min 10-15\text{ L/min} 10 − 15 L/min ) is contraindicated because his baseline S p O 2 SpO_2 Sp O 2 ​ of 89 % 89\% 89% reflects chronic CO2 retention dependent on peripheral hypoxic drive; high-flow oxygen will suppress breathing and trigger carbon dioxide narcosis. The correct management is to administer Salbutamol (2–4 puffs via spacer) , sit the patient upright, and if supplemental oxygen is required, titrate via a 24% or 28% Venturi mask targeting an S p O 2 SpO_2 Sp O 2 ​ strictly within 88% to 92% . If acute respiratory distress fails to resolve, summon an emergency ambulance (999). Tooth extraction is deferred until the acute respiratory exacerbation has resolved.